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Abstract 
KLRK1 encodes a type II transmembrane-anchored 
glycoprotein that is expressed as a disulfide-linked 
homodimer on the surface of Natural Killer (NK) 
cells, gamma/delta TcR+ T cells, CD8+ T cells, and 
a minor subset of CD4+ T cells. It associates non-
covalently with the DAP10 signaling protein and 
provides activating or costimulatory signals to NK 
cells and T cells. NKG2D binds to a family of 
glycoproteins, in humans the MICA, MICB, and 
ULBP1-6 membrane proteins, which are frequently 
expressed on cells that have become infected with 
pathogens or undergone transformation. 
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Identity 
Other names: D12S2489E, CD314, KLR, NKG2-
D, NKG2D 
HGNC (Hugo): KLRK1 
Location: 12p13.2 
 
DNA/RNA 
Note 
KLRK1 is present on chromosome 12 within a 
cluster of genes referred to as the "NK complex" 
(NKC) because several genes that are preferentially 
expressed by Natural Killer (NK) cells are located 
in this region, including on the centromeric side 
KLRD1 (CD94) and on the telomeric side KLRC4 
(NKG2F), KLRC3 (NKG2E), KLRC2 (NKG2C), 
and KLRC1 (NKG2A) (Houchins et al., 1991). 
Description 
The KLRK1 gene is 17702 bases located on the 
negative strand of chromosome 12 spanning bases 
10372353 to 103900054 with a predicted 7 exons. 
Transcription 
There is evidence for alternative splicing of 
KLRK1, but only one isoform encoding a 
functional protein has been described in humans.  
In one of the KLRK1 splice variants the fourth 
exon of KLRC4 is spliced to the 5-prime end of 
KLRK1.  
 
 
Schematic representation of the KLRC2 (NKG2C), KLR3 (NKG2E), KLRC4 (NKG2F), and KLRK1 genes on human chromosome 
12p13.2 (taken from Glienke et al., 1998, figure 4). 
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Amino acid sequence of KLRK1 is shown, with the predicted transmembrane domain underlined. The R residue in the 
transmembrane is required for association of KLRK1 with the DAP10 signaling protein to form the mature receptor complex. 
Three potential sites for N-linked glycosylation are in bold. 
 
 
KLRK1 is transcribed by NK cells, gamma/delta-
TcR+ T cells, CD8+ T cells and some CD4+ T cells 
(Bauer et al., 1999). Transcription of KLRK1 is 
enhanced by stimulation of NK cells with IL-2 or 
IL-15 and decreased by culture with TGF-beta. 
Pseudogene 
No known pseudogenes. 
Protein 
Note 
KLRK1 is a type II transmembrane-anchored 
membrane glycoprotein expressed as a disulfide-
bonded homodimer on the cell surface. Expression 
of KLRK1 on the cell surface requires its 
association with DAP10, which is a type I adapter 
protein expressed as a disulfide-bonded homodimer 
(Wu et al., 1999). On the cell surface, the receptor 
complex is a hexamer; two disulfide-bonded 
KLRK1 homodimers each paired with two DAP10 
disulfide-bonded homodimers (Garrity et al., 2005). 
A charged amino acid residue (aspartic acid) 
centrally located within the transmembrane region 
of DAP10 forms a salt bridge with a charged amino 
acid residue (arginine) in the transmembrane region 
of KLRK1 to stabilize the receptor complex (Wu et 
al., 1999). 
Description 
KLRK1 is a type II membrane protein comprising 
216 amino acids with a predicted molecular weight 
of 25,143 kDa. The protein has an N-terminal 
intracellular region, a transmembrane domain, a 
membrane-proximal stalk region, and an 
extracellular region with a single C-type lectin-like 
domain. KLRK1 is expressed on the cell surface as 
a disulfide-bonded homodimer with a molecular 
weight of approximately 42 kDa when analyzed 
under reducing conditions and approximately 80 
kDa under non-reducing conditions. A cysteine 
residue just outside the transmembrane region 
forms the disulfide bond joining the two subunits of 
the homodimer. There are three potential sites for 
N-linked glycosylation in the extracellular region of 
KLRK1. Treatment of the KLRK1 glycoprotein 
with N-glycanase reduces the molecular weight to 
approximately the size of the core polypeptide. 
 
Schematic representation of the KLRK1 (NKG2D) - DAP10 
receptor complex (taken from Garrity et al., 2005, figure 7). 
Expression 
KLRK1 protein is expressed on the cell surface of 
NK cells, gamma/delta-TcR+ T cells, CD8+ T cells, 
and some CD4+ T cells (Bauer et al., 1999). 
Localisation 
KLRK1 is expressed as a type II integral membrane 
glycoprotein on the cell surface of NK cells, 
gamma/delta-TcR+ T cells, CD8+ T cells, and 
some CD4+ T cells (Bauer et al., 1999).  
In the absence of DAP10, KLRK1 protein is 
retained in the cytoplasm and degraded (Wu et al., 
1999). 
Function 
KLRK1 binds to at least eight distinct ligands: 
MICA, MICB, ULBP-1, ULBP-2, ULBP-3, ULBP-
4, ULBP-5, and ULBP-6 (Bauer et al., 1999; 
Cosman et al., 2001; Raulet et al., 2013).  
These ligands are type I glycoproteins with 
homology to MHC class I. The KLRK1 ligands 
frequently are over-expressed on tumor cells, virus-
infected cells, and "stressed" cells (Raulet et al., 
2013). The crystal structure of KLRK1 bound to 
MICA has been described (Li et al., 2001). After 
binding to its ligand, KLRK1 transmits an 
activating signal via the DAP10 adapter subunit.  
DAP10 has a YINM motif in its cytoplasmic 
domain, which upon tyrosine phosphorylation binds 
to Vav and the p85 subunit of PI3-kinase (Billadeau 
et al., 2003; Wu et al., 1999), causing a downstream 
cascade of signaling in T cells and NK cells, 
resulting in the killing of ligand-bearing cells and 
the secretion of cytokines by NK cells and T cells. 
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Structure of the KLRK1 homodimer (a) and its ligand MICA 
(b) (taken from Li et al., 2001, figure 1). 
Homology 
Pan troglodytes: NP_001009059 
Macaca mulatta: NP_001028061 
Macaca fascicularis: CAD19993 
Callithrix jacchus: ABN45890 
Papio anubis: ABO09749 
Pongo pygmaeus: Q8MJH1 
Bos taurus: CAJ27114 
Sus scrofa: Q9GLF5 
Mus musculus: NP_149069 
Mus musculus: NP_001076791 
Rattus norvegicus: NP_598196 
Callithrix jacchus: A4GHD0 
Neovison vison: U6DVF4 
Microcebus murinus: D1GEY1 
Varecia variegate: D1GF00 
Lithobates catesbeiana: C1C4X9 
Mutations 
Note 
None identified. 
Implicated in 
Cancer 
Note 
Many types of cancer (carcinomas, sarcomas, 
lymphomas, and leukemias) over-express the 
ligands for KLRK1 (Raulet et al., 2013). In some 
cases, this renders the tumor cells susceptible to 
killing by activated KLRK1-bearing NK cells. 
Some tumors shed or secrete soluble ligands that 
bind to KLRK1, which downregulates expression 
of KLRK1 on NK cells and T cells (Groh et al., 
2002), although the physiological relevance of the 
shed ligands is controversial. Mice in which the 
Klrk1 gene has been disrupted show increased 
susceptibility to certain cancers caused by 
transgenic expression of oncogenes (Guerra et al., 
2008). 
Viral infection 
Note 
Viral infection of cells can induce transcription and 
cell surface expression of ligands for KLRK1, 
rendering these infected cells susceptible to attack 
by NK cells and T cells (Champsaur and Lanier, 
2010; Raulet et al., 2013). Some viruses, for 
example cytomegalovirus, encode proteins that 
intercept the ligand proteins intracellularly and 
prevent their expression on the surface of virus-
infected cells. 
Rheumatoid arthritis 
Note 
An expansion of CD4+,CD28- T cells expressing 
KLRK1 was observed in the joints of patients with 
rheumatoid arthritis and KLRK1 ligands were 
detected on synovial cells in the inflamed tissue 
(Groh et al., 2003). 
Type I diabetes 
Note 
Peripheral blood NK cells and T cells in patients 
with type I diabetes demonstrate a slightly 
decreased amount of expression of KLRK1 on the 
cell surface, independent disease duration (Rodacki 
et al., 2007), similar to prior observations in the 
NOD mouse (Ogasawara et al., 2003). 
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